PCT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
PureCycle Technologies Inc (PCT) is not a strong buy for a beginner investor with a long-term focus at this time. While the company has potential due to its patented technology and large addressable market, the financial performance, hedge fund selling, and delayed commercial ramp present significant risks. The stock's technical indicators and options sentiment do not strongly support an immediate buy decision.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is neutral, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its pivot level of 5.522, with resistance at 6.016 and support at 5.027. Overall, the technical indicators suggest caution.
The company benefits from patented and exclusive technology through Procter & Gamble, and analysts remain optimistic about its long-term potential in a large addressable market.
Hedge funds are aggressively selling, with an 808.33% increase in selling activity last quarter. The company's commercial ramp continues to face delays, and financial performance has deteriorated significantly, with net income dropping by 70.95% YoY in Q4 2025.
In Q4 2025, revenue remained flat at $2.695M YoY. However, net income dropped significantly to -$18.787M (-70.95% YoY), and EPS fell to -0.1 (-74.36% YoY). Despite a 100% gross margin, the company's financials indicate poor profitability and growth trends.
Analysts have lowered price targets from $16 to $14 while maintaining Outperform and Overweight ratings. They cite delays in the commercial ramp and reduced revenue forecasts for 2026, though they remain optimistic about long-term potential.
